» Articles » PMID: 29212199

Klf4 Reduces Stemness Phenotype, Triggers Mesenchymal-epithelial Transition (MET)-like Molecular Changes, and Prevents Tumor Progression in Nasopharygeal Carcinoma

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Dec 8
PMID 29212199
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The reprogramming factor Krüppel-like factor 4 (Klf4), one of the Yamanaka's reprogramming factors, plays an essential role in reprogramming somatic cells into induced pluripotent stem cells (iPSCs). Klf4 is dysregulated and displays divergent functions in multiple malignancies, but the biological roles of Klf4 in nasopharyngeal carcinoma (NPC) remain unknown. The present study revealed that Klf4 downregulation in a cohort of human NPC biopsies is significantly associated with invasive and metastatic phenotypes of NPC. Our results showed exogenous expression of Klf4 significantly inhibited cell proliferation, decreased stemness, triggered mesenchymal-epithelial transition (MET)-like molecular changes, and suppressed migration and invasion of NPC cells, whereas depletion of endogeneous Klf4 by RNAi reversed the aforementioned biological behaviors and characheristics. Klf4 silencing significantly enhanced the metastatic ability of NPC cells . In addition, CHIP assay confirmed that E-cadherin is a transcriptional target of Klf4 in NPC cells. Additional studies demonstrated that Klf4-induced MET-like cellular marker alterations, and reduced motility and invasion of NPC cells were mediated by E-cadherin. This study revealed the clinical correlation between Klf4 expression and epithelial-mesenchymal transition (EMT) biomarkers (including its target gene E-cadherin) in a cohort of NPC biopsies. Taken together, our findings suggest, for what we believe is the first time, that Klf4 functions as a tumor suppressor in NPC to decrease stemness phenotype, inhibit EMT and prevent tumor progression, suggesting that restoring Klf4 function may provide therapeutic benefits in NPC.

Citing Articles

Characterizing tumor biology and immune microenvironment in high-grade serous ovarian cancer via single-cell RNA sequencing: insights for targeted and personalized immunotherapy strategies.

Zhao F, Jiang X, Li Y, Huang T, Xiahou Z, Nie W Front Immunol. 2025; 15:1500153.

PMID: 39896800 PMC: 11782144. DOI: 10.3389/fimmu.2024.1500153.


MACC1 ablation suppresses the dedifferentiation process of non-CSCs in lung cancer through stabilizing KLF4.

Li Z, Wang S, Guo T, Yan X, Chen C, Zhang W Cell Death Discov. 2024; 10(1):494.

PMID: 39695175 PMC: 11655558. DOI: 10.1038/s41420-024-02256-0.


The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations.

Masciale V, Banchelli F, Grisendi G, Samarelli A, Raineri G, Rossi T J Biol Chem. 2024; 300(12):107994.

PMID: 39547513 PMC: 11714729. DOI: 10.1016/j.jbc.2024.107994.


ThermomiR-377-3p-induced suppression of Cirbp expression is required for effective elimination of cancer cells and cancer stem-like cells by hyperthermia.

Lin T, Jia J, Luo W, Lin X, Xiao S, Yang J J Exp Clin Cancer Res. 2024; 43(1):62.

PMID: 38419081 PMC: 10903011. DOI: 10.1186/s13046-024-02983-3.


Current Advances in Corneal Stromal Stem Cell Biology and Therapeutic Applications.

Volatier T, Cursiefen C, Notara M Cells. 2024; 13(2).

PMID: 38247854 PMC: 10814767. DOI: 10.3390/cells13020163.


References
1.
Liu Z, Yang H, Luo W, Jiang Q, Mai C, Chen Y . Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma. Histopathology. 2013; 63(3):362-70. DOI: 10.1111/his.12176. View

2.
Tiwari N, Meyer-Schaller N, Arnold P, Antoniadis H, Pachkov M, van Nimwegen E . Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8). PLoS One. 2013; 8(2):e57329. PMC: 3581489. DOI: 10.1371/journal.pone.0057329. View

3.
Shields J, Christy R, Yang V . Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest. J Biol Chem. 1996; 271(33):20009-17. PMC: 2330254. DOI: 10.1074/jbc.271.33.20009. View

4.
Koopmansch B, Berx G, Foidart J, Gilles C, Winkler R . Interplay between KLF4 and ZEB2/SIP1 in the regulation of E-cadherin expression. Biochem Biophys Res Commun. 2013; 431(4):652-7. DOI: 10.1016/j.bbrc.2013.01.070. View

5.
Moral M, Segrelles C, Martinez-Cruz A, Lorz C, Santos M, Garcia-Escudero R . Transgenic mice expressing constitutively active Akt in oral epithelium validate KLFA as a potential biomarker of head and neck squamous cell carcinoma. In Vivo. 2009; 23(5):653-60. PMC: 2909848. View